236 related articles for article (PubMed ID: 2142455)
1. Analysis of T cell receptor V beta gene usage in primary mixed lymphocyte reactions: evidence for directive usage by different antigen-presenting cells and Mls-like determinants on T cell blasts.
Larsson-Sciard EL; Spetz-Hagberg AL; Casrouge A; Kourilsky P
Eur J Immunol; 1990 Jun; 20(6):1223-9. PubMed ID: 2142455
[TBL] [Abstract][Full Text] [Related]
2. Bacterial proteins that mediate the association of a defined subset of T cell receptor:CD4 complexes with class II MHC.
Yagi J; Baron J; Buxser S; Janeway CA
J Immunol; 1990 Feb; 144(3):892-901. PubMed ID: 2136903
[TBL] [Abstract][Full Text] [Related]
3. Role of Mls-1 locus and clonal deletion of T cells in susceptibility to collagen-induced arthritis in mice.
Anderson GD; Banerjee S; Luthra HS; David CS
J Immunol; 1991 Aug; 147(4):1189-93. PubMed ID: 1907992
[TBL] [Abstract][Full Text] [Related]
4. Evidence that Mls-2 antigens which delete V beta 3+ T cells are controlled by multiple genes.
Pullen AM; Marrack P; Kappler JW
J Immunol; 1989 May; 142(9):3033-7. PubMed ID: 2496158
[TBL] [Abstract][Full Text] [Related]
5. Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice.
Infante AJ; Levcovitz H; Gordon V; Wall KA; Thompson PA; Krolick KA
J Immunol; 1992 Jun; 148(11):3385-90. PubMed ID: 1375242
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the in vitro presentation of minor lymphocyte stimulating determinants by major histocompatibility complex-encoded immune response genes.
Ryan JJ; Miner DW; Mond JJ; Finkelman FD; Woody JN
J Immunol; 1987 Apr; 138(8):2392-401. PubMed ID: 2435797
[TBL] [Abstract][Full Text] [Related]
7. Anti-T-cell receptor V beta 6 breaks tolerance in Mlsa mice and induces production of anti-Mlsa antibodies.
Matossian-Rogers A; de Giorgi L
Immunology; 1993 Jan; 78(1):122-6. PubMed ID: 8436397
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the Mlsf system. I. A novel "polymorphism" of endogenous superantigens.
Abe R; Foo-Phillips M; Granger LG; Kanagawa O
J Immunol; 1992 Dec; 149(11):3429-39. PubMed ID: 1331235
[TBL] [Abstract][Full Text] [Related]
9. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes.
Frandji P; Tkaczyk C; Oskeritzian C; David B; Desaymard C; Mécheri S
Eur J Immunol; 1996 Oct; 26(10):2517-28. PubMed ID: 8898968
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a new minor lymphocyte stimulatory system. I. Cluster of self antigens recognized by "I-E-reactive" V beta s, V beta 5, V beta 11, and V beta 12 T cell receptors for antigen.
Abe R; Kanagawa O; Sheard MA; Malissen B; Foo-Phillips M
J Immunol; 1991 Aug; 147(3):739-49. PubMed ID: 1713604
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of superantigen recognition by peptides of the variable region of the T cell receptor beta chain.
MacNeil D; Fraga E; Singh B
Eur J Immunol; 1992 Apr; 22(4):937-41. PubMed ID: 1532364
[TBL] [Abstract][Full Text] [Related]
12. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E; Takacs K; Altmann DM
Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
[TBL] [Abstract][Full Text] [Related]
13. Self-tolerance alters T-cell receptor expression in an antigen-specific MHC restricted immune response.
Fry AM; Matis LA
Nature; 1988 Oct; 335(6193):830-2. PubMed ID: 2847051
[TBL] [Abstract][Full Text] [Related]
14. Two separate mechanisms of T cell clonal anergy to Mls-1.
Yui K; Ishida Y; Katsumata M; Komori S; Chused TM; Abe R
J Immunol; 1993 Dec; 151(11):6062-75. PubMed ID: 8245451
[TBL] [Abstract][Full Text] [Related]
15. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of the presentation of minor lymphocyte-stimulating determinants. II. Differing non-MHC control of super-stimulatory and more poorly stimulatory Mls phenotypes.
Ryan JJ; LeJeune HB; Mond JJ; Finkelman FD
J Immunol; 1990 Apr; 144(7):2506-17. PubMed ID: 2138649
[TBL] [Abstract][Full Text] [Related]
17. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
Dennig D; Yan Y; Ferguson K; O'Reilly RJ
Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
[TBL] [Abstract][Full Text] [Related]
18. Production of minor lymphocyte stimulatory-1a antigen from activated CD4+ or CD8+ T cells.
Arase-Fukushi N; Arase H; Ogasawara K; Good RA; Onoé K
J Immunol; 1993 Nov; 151(9):4445-54. PubMed ID: 8104995
[TBL] [Abstract][Full Text] [Related]
19. Evidence for quantitative and qualitative differences in functional activation of Mls-reactive T cell clones and hybridomas by antigen or TcR/CD3 antibodies.
Gaugler B; Langlet C; Martin JM; Schmitt-Verhulst AM; Guimezanes A
Eur J Immunol; 1991 Oct; 21(10):2581-9. PubMed ID: 1680703
[TBL] [Abstract][Full Text] [Related]
20. Expression of Mls determinants in mice exhibiting the severe combined immunodeficiency (scid) mutation or X-linked immunodeficiency (xid) defect.
Roberts JL; Abe R; Shores EW; Singer A
J Immunol; 1992 Sep; 149(5):1577-82. PubMed ID: 1506683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
